Tetra Bio-Pharma Resumes its Phase 3 Clinical Trial Program
Tetra Bio-Pharma Inc. today announced it is ready to resume its Phase 3 clinical program in advanced cancer pain patients with the objective to assess Health- Related Quality of Life (HrQoL).